Evidence map›Paper›PMID 30099753›Full record

ArticleClinical and experimental immunology2018

Immunogenicity of meningococcal polysaccharide ACWY vaccine in primary immunized or revaccinated adults.

C Ferlito, R Biselli, M S Cattaruzza, R Teloni, S Mariotti, E Tomao, G Salerno, M S Peragallo, P Lulli, S Caporuscio and 8 more

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical and experimental immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 1 country.

C FerlitoSapienza Università di Roma, Dipartimento di Medicina Clinica e Molecolare, Azienda Ospedaliera Universitaria S. Andrea, Rome, Italy.
R BiselliAeronautica Militare Italiana, Comando Logistico, Servizio Sanitario, Rome, Italy.
M S CattaruzzaSapienza Università di Roma, Dipartimento di Sanità Pubblica e Malattie Infettive, Rome, Italy.
R TeloniIstituto Superiore di Sanità, Dipartimento Malattie Infettive, Rome, Italy.
S MariottiIstituto Superiore di Sanità, Dipartimento Malattie Infettive, Rome, Italy.
E TomaoAeronautica Militare Italiana, Corpo Sanitario, Rome, Italy.
G SalernoSapienza Università di Roma, Dipartimento di Medicina Clinica e Molecolare, Azienda Ospedaliera Universitaria S. Andrea, Rome, Italy.
M S PeragalloEsercito Italiano, Centro Studi e Ricerche di Sanità e Veterinaria, Rome, Italy.
P LulliSapienza Università di Roma, Dipartimento di Medicina Clinica e Molecolare, Azienda Ospedaliera Universitaria S. Andrea, Rome, Italy.
S CaporuscioSapienza Università di Roma, Dipartimento di Medicina Clinica e Molecolare, Azienda Ospedaliera Universitaria S. Andrea, Rome, Italy.
A AutoreAeronautica Militare, Comando Logistico, Centro Sperimentale di Volo, Aeroporto Pratica di Mare, Rome, Italy.
G BizzarroAeronautica Militare, Comando Logistico, Centro Sperimentale di Volo, Aeroporto Pratica di Mare, Rome, Italy.
V GermanoSapienza Università di Roma, Dipartimento di Medicina Clinica e Molecolare, Azienda Ospedaliera Universitaria S. Andrea, Rome, Italy.
M I BiondoSapienza Università di Roma, Dipartimento di Medicina Clinica e Molecolare, Azienda Ospedaliera Universitaria S. Andrea, Rome, Italy.
A Picchianti DiamantiSapienza Università di Roma, Dipartimento di Medicina Clinica e Molecolare, Azienda Ospedaliera Universitaria S. Andrea, Rome, Italy.
S SalemiSapienza Università di Roma, Dipartimento di Medicina Clinica e Molecolare, Azienda Ospedaliera Universitaria S. Andrea, Rome, Italy.
R NisiniIstituto Superiore di Sanità, Dipartimento Malattie Infettive, Rome, Italy.
R D'AmelioSapienza Università di Roma, Dipartimento di Medicina Clinica e Molecolare, Azienda Ospedaliera Universitaria S. Andrea, Rome, Italy.
Sapienza University of Rome · ITAzienda Ospedaliera Sant'Andrea · ITIstituto Superiore di Sanità · ITServizio Sanitario Nazionale · ITItalian Resuscitation Council · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Meningococcal polysaccharide (Men-Ps) vaccine immunogenicity following either primary immunization or revaccination in adults was evaluated. The study population consisted of subjects who have received tetravalent Men-Ps vaccine once (group 1) or at least twice, with a 2-6 dose range (group 2). Human leucocyte antigen (HLA)-typing was performed by polymerase chain reaction and specific immunoglobulin (Ig)G was measured by enzyme-linked immunosorbent assay. Nine months post-immunization, the percentages of individuals with levels of anti-Men-Ps IgG ≥ 2 µg/ml were comparable in both groups, with the exception of anti-Men-PsW

Indexed as

AdultAntibodies, BacterialFemaleHistocompatibility TestingHumansImmunization, SecondaryImmunoglobulin GMaleMeningitis, MeningococcalMeningococcal VaccinesMilitary PersonnelNeisseria meningitidisPolysaccharides, BacterialVaccinationYoung AdultAntibodies, BacterialImmunoglobulin GMeningococcal VaccinesPolysaccharides, Bacterialantibodiesbacterialvaccination

Identifiers

PMID30099753
PMCPMC6231002
OpenAlexW2885439384

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.